Hepatitis B vaccine: patient group direction template
Patient group direction (PGD) template to help provide hepatitis B vaccine to individuals before and after exposure to hepatitis B.
Applies to England
Documents
Details
This patient group direction (PGD) template supports the provision of hepatitis B vaccine to individuals considered at increased risk of exposure to hepatitis B virus, at increased risk of complications of hepatitis B disease, or after a potential exposure to hepatitis B virus. It may also be used to vaccinate children with incomplete or unknown immunisation status against hepatitis B.
The hepatitis B PGD version 05.00 is valid from 31 October 2023 to 30 April 2025.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and summary of product characteristics for the vaccine.
Updates to this page
Last updated 10 October 2023 + show all updates
-
Added version 05.00 – see page 2 for change history.
-
Added v04.00.
-
Added version 03.00. See page 2 for change history.
-
Replaced PGD template with updated version.
-
First published.